AbClon Inc. (KOSDAQ:174900)
62,400
+3,000 (5.05%)
Feb 9, 2026, 9:29 AM KST
AbClon Market Cap
AbClon has a market cap or net worth of 1.18 trillion as of February 6, 2026. Its market cap has increased by 368.44% in one year.
Market Cap
1.18T
Enterprise Value
1.18T
Revenue
3.80B
Ranking
n/a
PE Ratio
n/a
Stock Price
62,400.00
Market Cap Chart
Since September 18, 2017, AbClon's market cap has increased from 176.80B to 1.18T, an increase of 569.44%. That is a compound annual growth rate of 25.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 1.18T | 45.71% |
| Dec 30, 2025 | 812.27B | 230.14% |
| Dec 30, 2024 | 246.04B | 6.90% |
| Dec 28, 2023 | 230.16B | 17.39% |
| Dec 29, 2022 | 196.07B | -27.49% |
| Dec 30, 2021 | 270.42B | -48.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aimed Bio | 3.36T |
| Rznomics | 1.79T |
| AprilBio | 1.38T |
| Qurient | 1.31T |
| JS Link | 952.68B |
| Inventage Lab | 884.23B |
| ROKIT Healthcare | 816.74B |
| Curocell | 686.79B |